How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,859 results for

E/M Examination Criteria

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. AIUM Practice Guideline for the Performance of an Ultrasound Examination of Solid-Organ Transplants

to advance this mission. Practice guidelines of the AIUM are intended to provide the medical ultrasound community with guidelines for the performance and record- ing of high-quality ultrasound examinations. The guidelines reflect what the AIUM considers the minimum criteria for a complete exami- nation in each area but are not intended to establish a legal standard of care. AIUM-accredited practices are expected to generally follow the guidelines with recognition that deviations from these guidelines (...) or segmental arteries in the upper pole, interpolar region, and lower pole of the transplanted kidney should include the RI and may include the AT if a tardus parvus waveform is present. e. Intrarenal Veins—Color Doppler images and/or spectral Doppler waveforms may be obtained to assess venous flow within the transplant. C. Pancreas Transplant Grayscale, color Doppler, and spectral Doppler examinations of a pancreas transplant should be performed. Before the ultrasound examination, the surgical anatomy

2014 American Institute of Ultrasound in Medicine

62. Screening Pelvic Examination in Adult Women

, Peters R . Perception, attitude and practices of women towards pelvic examination and Pap smear in Jamaica. N Am J Med Sci 2010 2 478 86 Hesselius I , Lisper HO , Nordström A , Anshelm-Olson B , Odlund B . Comparison between participants and non-participants at a gynaecological mass screening. Scand J Soc Med 1975 3 129 38 Wijma B , Gullberg M , Kjessler B . Attitudes towards pelvic examination in a random sample of Swedish women. Acta Obstet Gynecol Scand 1998 77 422 8 Armstrong L , Zabel E (...) , Beydoun HA . Evaluation of the usefulness of the ‘hormones with optional pelvic exam' programme offered at a family planning clinic. Eur J Contracept Reprod Health Care 2012 17 307 13 Osofsky HJ . Women's reactions to pelvic examination. Obstet Gynecol 1967 30 146 51 Hoyo C , Yarnall KS , Skinner CS , Moorman PG , Sellers D , Reid L . Pain predicts non-adherence to pap smear screening among middle-aged African American women. Prev Med 2005 41 439 45 Taylor VM , Yasui Y , Burke N , Nguyen T , Acorda E

2014 American College of Physicians

63. AIUM Practice Parameter for the Performance of a Thyroid and Parathyroid Ultrasound Examination

-quality ultrasound examinations. The parameters re?ect what the AIUM considers the minimum criteria for a complete examination in each area but are not intended to establish a legal standard of care. AIUM-accredited practices are expected to generally follow the parameters with recognition that deviations from these parameters will be needed in some cases, depending on patient needs and available equipment. Practices are encouraged to go beyond the parameters to provide additional ser- vice (...) ) Committee.JAmCollRadiol 2015; 12: 1272–1279. 11. Burke CJ, Thomas RH, Howlett D. Imaging the major salivary glands. Br J Oral Maxillofac Surg 2011; 49:261–269. 12. Lee YY, Wong KT, King AD, Ahuja AT. Imaging of salivary gland tumours. Eur J Radiol 2008; 66:419–436. 13. Cornec D, Jousse-Joulin S, Pers JO, et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjogren’s syndrome: toward new diagnostic criteria? Arthritis Rheum 2013; 65:216–225. 14. Theander E, Mandl T. Primary Sjogren’s syndrome

2013 American Institute of Ultrasound in Medicine

64. AIUM Practice Parameter for the Performance of an Ultrasound Examination for Detection and Assessment of Developmental Dysplasia of the Hip

for the perfor- mance and recording of high-quality ultrasound examinations. The parameters re?ect what the AIUM considers the minimum criteria for a complete examination in each area but are not intended to establish a legal standard of care. AIUM-accredited practices are expected to generally follow the parameters with recognition that deviations from these parameters will be needed in some cases, depending on patient needs and available equipment. Practices are encouraged to go beyond the parameters (...) in the diagnosis of developmen- tal hip dysplasia. Radiology 2007; 242:355–359. 2. Smergel E, Losik SB, Rosenberg HK. Sonography of hip dysplasia. Ultrasound Q 2004; 20:201–216. 3. Bache CE, Clegg J, Herron M. Risk factors for developmental dys- plasia of the hip: ultrasonographic ?ndings in the neonatal period. J Pediatr Orthop B 2002; 11:212–218. 4. Mulpuri K, Song KM, Gross RH, et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on detection and nonoperative management of pediatric

2013 American Institute of Ultrasound in Medicine

65. AIUM Practice Parameter for the Performance of Ultrasound Examinations of the Head and Neck

interests in medical diagnostic ultrasound, and, with hundreds of volunteers, the AIUM has promoted the safe and effective use of ultra- sound in clinical medicine for more than 50 years. This document and others like it will continue to advance this mission. Practice parameters of the AIUM are intended to provide the medical ultrasound community with parameters for the performance and recording of high-quality ultrasound examinations. The parameters reflect what the AIUM considers the minimum criteria (...) as follows: A. Salivary glands; B. Lymph nodes; C. Congenital lesions; D. Miscellaneous mass lesions; E. Infection and trauma; and F. Endocrine. The conditions listed within these categories represent some but not all of those encountered by the clinician who works in this area. V . Specifications for Individual Examinations A. Salivary Glands (Sublingual, Submandibular, and Parotid) 1. Indications for a salivary gland ultrasound examination include but are not limited to the following: • Diffuse

2013 American Institute of Ultrasound in Medicine

66. Examining the Effects of a Team-based Running Program

patients. South African Journal of Sports Medicine. 2013;25(2):55. doi: 10.7196/SAJSM.481. Quelhas Martins A, Kavussanu M, Willoughby A, Ring C. Moderate intensity exercise facilitates working memory. Psychology of Sport and Exercise. 2013;14(3):323-328. doi: 10.1016/j.psychsport.2012.11.010 Dal Grande E, Taylor A, Wilson D. South australian health and wellbeing survey, december 2000. Centre for Population Studies in Epidemiology. 2002. Rosenberg M. Society and the adolescent self-image. Princeton, NJ (...) Examining the Effects of a Team-based Running Program Examining the Effects of a Team-based Running Program - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Examining the Effects of a Team-based Running

2017 Clinical Trials

67. Examining the Effects of an Improvisation Group

. Kendall, P.C., Robin, J.A., Hedtke, K.A., Suveg, C., Flannery-Schroeder, E. & Gosch, E. (2005). Considering CBT with Anxious Youth? Think Exposures. Cognitive and Behavioural Practice, 12, 136-150. Kindler, R.C. & Gray, A.A. (2010). Theater and Therapy: How Improvisation Informs the Analytic Hour. Psychoanalytic Inquiry, 30, 254-266. doi: 10.1080/07351690903206223 Sheesley, A.P., Pfeffer, M. & Barish, B. (2016). Comedic Improv Therapy for the Treatment of Social Anxiety Disorder. Journal of Creativity (...) Examining the Effects of an Improvisation Group Examining the Effects of an Improvisation Group - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Examining the Effects of an Improvisation Group The safety

2017 Clinical Trials

68. Multi-criteria decision analysis for the appraisal of medical needs: a pilot study

: ? the conditions for and level of reimbursement, ? the cohort of patients eligible for ETR (i.e. inclusion- and exclusion criteria) and ? the budget needed for covering the product. Cohort decisions are defined by law e as decisions restricted in time and based on available economic and medical data. The budget is defined yearly. The agent who submits a request for a cohort decision is responsible for the execution of the programme, the designation of a responsible physician for handling the requests (...) a cohort decision exists for that patients’ indication and whether the patient satisfies the eligibility criteria. Patients who are included in the ETR programme have to give their informed consent. e Art. 25quater/1, §1 of the Wet betreffende de verplichte verzekering voor geneeskundige verzorging en uitkeringen, gecoördineerd op 14 juli 1994 KCE Report 272 Multi-criteria decision analysis for the appraisal of medical needs 11 Key points ? The unmet medical needs procedures foresees in the possibility

2016 Belgian Health Care Knowledge Centre

69. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Published in the March 2015 issue of Genetics in M Full Text available with Trip Pro

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Published in the March 2015 issue of Genetics in M Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Genetics in Medicine Thank you (...) , this recommendation describes a process for classifying variants into these five categories based on criteria using typical types of variant evidence (e.g., population data, computational data, functional data, segregation data). Because of the increased complexity of analysis and interpretation of clinical genetic testing described in this report, the ACMG strongly recommends that clinical molecular genetic testing should be performed in a Clinical Laboratory Improvement Amendments–approved laboratory

2015 Association for Molecular Pathology

70. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update ISHLT GUIDELINE The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update Mandeep R. Mehra, MD (Chair), Charles E. Canter, MD, Margaret M. Hannan, MD, Marc J. Semigran, MD, Patricia A. Uber, PharmD, David A. Baran, MD, Lara Danziger-Isakov, MD, MPH, James K. Kirklin, MD, Richard Kirk, MD, Sudhir S. Kushwaha (...) , to exclude intrinsic renal disease. It is reasonable to consider the presence of irreversible renal dysfunction (eGFR o 30 ml/min/1.73 m 2 ) as a relative contraindication for heart transplantation alone (Class IIa, Level of Evidence: C). Continued on page 4 Mehra et al. ISHLT Listing Criteria for HT 3Table 1 (Continued) 2006 Guideline recommendation 2016 Guideline recommendation Clinically severe symptomatic cerebrovascular disease, which is not amenable to revascularization, may be considered

2016 International Society for Heart and Lung Transplantation

71. Medical eligibility criteria for contraceptive use

Medical eligibility criteria for contraceptive use Department of Reproductive Health and Research World Health Organization Avenue Appia 20, CH-1211 Geneva 27 Switzerland Fax: +41 22 791 4171 E-mail: reproductivehealth@who.int www.who.int/reproductivehealth For more information, please contact: COCs Barrier methods IUDs Fertility awareness-based methods Lactational Coitus interruptus Copper IUD for amenorrhoea Patch Female surgical sterilization Intrauterine devices CICs emergency contraception (...) study): incidence ratio 9.2 (95% CI 6.5–13) CI: confidence interval; OR: odds ratio. a Based on 5 studies, 4 of which reported incidence by week and 1 of which reported the proportion of VTE events by week. b Based on 6 studies.Medical eligibility criteria for contraceptive use - Part I | 37 References 1. Jackson E, Glasier A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol. 2011;117(3):657–62. 2. Petersen JF, Bergholt T, Nielsen AK, Paidas MJ

2015 World Health Organisation Guidelines

72. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke

for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , MD, MSc, FRCPC, FAHA, Chair , MD, FAHA, Vice-Chair , MD, MS, FAHA , MD , DO , MD , MD, MS, FAHA , MD, MBA, FAHA , PhD , MD, MS, FAHA , MD, MSc, FAHA , and MD, FAHA MD, MPH, FAHAon behalf of the American Heart Association Stroke Council and Council on Epidemiology and Prevention Bart M. Demaerschalk , Dawn O (...) . Kleindorfer , Opeolu M. Adeoye , Andrew M. Demchuk , Jennifer E. Fugate , James C. Grotta , Alexander A. Khalessi , Elad I. Levy , Yuko Y. Palesch , Shyam Prabhakaran , Gustavo Saposnik , Jeffrey L. Saver , and Eric E. Smith and on behalf of the American Heart Association Stroke Council and Council on Epidemiology and Prevention Originally published 22 Dec 2015 Stroke. 2016;47:581–641 You are viewing the most recent version of this article. Previous versions: Abstract Purpose— To critically review

2015 American Academy of Neurology

73. Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography Full Text available with Trip Pro

and the rationale for their application to help identify changes in valvar status associated with ARF are discussed below. These changes are listed in and and are analogous to valvular abnormalities also described in RHD in the recent World Heart Federation statement on that condition. Table 3. Doppler Findings in Rheumatic Valvulitis Pathological mitral regurgitation (all 4 criteria met) Seen in at least 2 views Jet length ≥2 cm in at least 1 view Peak velocity >3 m/s Pansystolic jet in at least 1 envelope (...) Pathological aortic regurgitation (all 4 criteria met) Seen in at least 2 views Jet length ≥1 cm in at least 1 view Peak velocity >3 m/s Pan diastolic jet in at least 1 envelope Loading conditions should be accounted for at time of echocardiography/Doppler assessment (see the section Differential Diagnosis of ARF for a full discussion). This table reflects an amalgam of the findings from the references listed in and other guideline statements , and also resembles findings described in rheumatic heart

2015 American Heart Association

74. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke Full Text available with Trip Pro

on Epidemiology and Prevention Bart M. Demaerschalk , Dawn O. Kleindorfer , Opeolu M. Adeoye , Andrew M. Demchuk , Jennifer E. Fugate , James C. Grotta , Alexander A. Khalessi , Elad I. Levy , Yuko Y. Palesch , Shyam Prabhakaran , Gustavo Saposnik , Jeffrey L. Saver , and Eric E. Smith and on behalf of the American Heart Association Stroke Council and Council on Epidemiology and Prevention Originally published 22 Dec 2015 Stroke. 2015;47:581–641 You are viewing the most recent version of this article (...) Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke | Stroke Search Hello Guest! Login to your account Email Password Keep me logged in Search April 2019 March 2019 February 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article

2015 American Heart Association

75. m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients

m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03634696 Recruitment Status : Recruiting First Posted

2018 Clinical Trials

76. Usability of m-health applications applied to Type 2 Diabetes Mellitus in Low and middle-income countries: A meta-analysis and systematic review

Usability of m-health applications applied to Type 2 Diabetes Mellitus in Low and middle-income countries: A meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content (...) of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Grant number(s) * Measures of effect * Measures of effect Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Grant number(s) Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria

2020 PROSPERO

77. Comparative effectiveness of m-health interventions for insomnia: a systematic review and network meta-analysis

Comparative effectiveness of m-health interventions for insomnia: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files (...) or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Grant number(s) * Measures of effect * Measures of effect Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Grant number(s) Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria

2020 PROSPERO

78. Effects of conventional resistance training on strength and structure of the m. quadriceps femoris in young and old populations. A systematic review with meta-regression of randomized controlled trials.

Effects of conventional resistance training on strength and structure of the m. quadriceps femoris in young and old populations. A systematic review with meta-regression of randomized controlled trials. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears (...) no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Grant number(s) * Measures of effect * Measures of effect Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Grant number(s) Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion

2020 PROSPERO

79. Efficacy and Safety of Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): a systematic review and network meta-analysis

Efficacy and Safety of Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content (...) of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Grant number(s) * Measures of effect * Measures of effect Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Grant number(s) Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria

2020 PROSPERO

80. Clinical Criteria for the Evaluation of Caries Lesions Around Restorations in Primary Teeth (CARDEC-03)

and then, will be monitored for two years. Reassessments will be performed by a blind examiner in relation to the child's allocation group, and the occurrence of outcomes will be assessed according to predefined criteria described for evaluation of restorations performed in the context of atraumatic restorative treatment. The primary outcome will be the need for restorative intervention during the follow-up of the restorations evaluated by the different criteria. This outcome is composed of several components (...) of the children according to the diagnosis criteria Outcome Measures Go to Primary Outcome Measures : Operative treatment needs of the evaluated restorations (success of restoration) [ Time Frame: 24 months ] The necessity to repair the evaluated restorations during the follow-up examinations will be assessed by the Roeleveld et al. (1996) criteria (scores 11, 12, 13 and 30) or Frencken et al. (1996) criteria (scores 2 and 3). The criteria are described below: Roeleveld et al. (1996): Score 11 - Restoration

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>